United States Cutaneous Lymphoma Consortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 183,777 | 55,408 | 128,369 | 108.4 | 0% |
| 2012 | 71,400 | 76,669 | −5,269 | 78.9 | 0% |
| 2013 | 101,025 | 110,752 | −9,727 | 53.6 | 0% |
| 2014 | 96,560 | 85,312 | 11,248 | 71.1 | 0% |
| 2015 | 126,880 | 114,479 | 12,401 | 54.3 | 0% |
| 2016 | 144,250 | 118,279 | 25,971 | 55.2 | 0% |
| 2017 | 165,565 | 173,473 | −7,908 | 37.1 | 0% |
| 2018 | 196,716 | 245,158 | −48,442 | 23.9 | 0% |
| 2019 | 181,550 | 204,460 | −22,910 | 27.3 | 0% |
| 2020 | 201,300 | 141,559 | 59,741 | 47.2 | 0% |
| 2021 | 99,933 | 124,040 | −24,107 | 51.5 | 0% |
| 2022 | 309,126 | 141,055 | 168,071 | 59.6 | 0% |
| 2023 | 232,631 | 230,206 | 2,425 | 36.6 | 0% |
In its most recent public year (2023), this organization brought in $2,425 more than it spent. Its reserves stood at about 36.6 months of spending, down from 108.4 in 2011. Staff pay was 0% of spending. $358,565 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
United States Cutaneous Lymphoma Consortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works